English
Segment disclosures
Company overviewIllumina, Inc.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · Core Illumina
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=ilmn:CoreIlluminaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-03-30 – 2026-06-28 | 1159000000 | USD | 20260731 | Open filing evidence |
| 2025-12-29 – 2026-06-28 | 2251000000 | USD | 20260731 | Open filing evidence |
| 2025-12-29 – 2026-03-29 | 1091000000 | USD | 20260504 | Open filing evidence |
| 2024-12-30 – 2025-12-28 | 4343000000 | USD | 20260212 | Open filing evidence |
| 2025-06-30 – 2025-09-28 | 1084000000 | USD | 20251031 | Open filing evidence |
| 2024-12-30 – 2025-09-28 | 3184000000 | USD | 20251031 | Open filing evidence |
Operating Segments · GRAIL Inc.
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=ilmn:GRAILInc.Member| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-12-30 – 2025-12-28 | 0 | USD | 20260212 | Open filing evidence |
| 2025-06-30 – 2025-09-28 | 0 | USD | 20251031 | Open filing evidence |
| 2024-12-30 – 2025-09-28 | 0 | USD | 20251031 | Open filing evidence |
Consumables · Microarray
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=ilmn:ConsumablesMember;us-gaap:StatementBusinessSegmentsAxis=ilmn:MicroarrayMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-03-30 – 2026-06-28 | 77000000 | USD | 20260731 | Open filing evidence |
| 2025-12-29 – 2026-06-28 | 149000000 | USD | 20260731 | Open filing evidence |
| 2025-12-29 – 2026-03-29 | 71000000 | USD | 20260504 | Open filing evidence |
| 2024-12-30 – 2025-12-28 | 288000000 | USD | 20260212 | Open filing evidence |
| 2025-06-30 – 2025-09-28 | 69000000 | USD | 20251031 | Open filing evidence |
| 2024-12-30 – 2025-09-28 | 212000000 | USD | 20251031 | Open filing evidence |
Consumables · Sequencing
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=ilmn:ConsumablesMember;us-gaap:StatementBusinessSegmentsAxis=ilmn:SequencingMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-03-30 – 2026-06-28 | 775000000 | USD | 20260731 | Open filing evidence |
| 2025-12-29 – 2026-06-28 | 1500000000 | USD | 20260731 | Open filing evidence |
| 2025-12-29 – 2026-03-29 | 726000000 | USD | 20260504 | Open filing evidence |
| 2024-12-30 – 2025-12-28 | 2939000000 | USD | 20260212 | Open filing evidence |
| 2025-06-30 – 2025-09-28 | 747000000 | USD | 20251031 | Open filing evidence |
| 2024-12-30 – 2025-09-28 | 2183000000 | USD | 20251031 | Open filing evidence |
Instruments · Microarray
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=ilmn:InstrumentsMember;us-gaap:StatementBusinessSegmentsAxis=ilmn:MicroarrayMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-03-30 – 2026-06-28 | 5000000 | USD | 20260731 | Open filing evidence |
| 2025-12-29 – 2026-06-28 | 7000000 | USD | 20260731 | Open filing evidence |
| 2025-12-29 – 2026-03-29 | 2000000 | USD | 20260504 | Open filing evidence |
| 2024-12-30 – 2025-12-28 | 17000000 | USD | 20260212 | Open filing evidence |
| 2025-06-30 – 2025-09-28 | 4000000 | USD | 20251031 | Open filing evidence |
| 2024-12-30 – 2025-09-28 | 13000000 | USD | 20251031 | Open filing evidence |
Instruments · Sequencing
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=ilmn:InstrumentsMember;us-gaap:StatementBusinessSegmentsAxis=ilmn:SequencingMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-03-30 – 2026-06-28 | 125000000 | USD | 20260731 | Open filing evidence |
| 2025-12-29 – 2026-06-28 | 243000000 | USD | 20260731 | Open filing evidence |
| 2025-12-29 – 2026-03-29 | 118000000 | USD | 20260504 | Open filing evidence |
| 2024-12-30 – 2025-12-28 | 465000000 | USD | 20260212 | Open filing evidence |
| 2025-06-30 – 2025-09-28 | 107000000 | USD | 20251031 | Open filing evidence |
| 2024-12-30 – 2025-09-28 | 311000000 | USD | 20251031 | Open filing evidence |
Product · Microarray
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=ilmn:MicroarrayMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-03-30 – 2026-06-28 | 82000000 | USD | 20260731 | Open filing evidence |
| 2025-12-29 – 2026-06-28 | 156000000 | USD | 20260731 | Open filing evidence |
| 2025-12-29 – 2026-03-29 | 73000000 | USD | 20260504 | Open filing evidence |
| 2024-12-30 – 2025-12-28 | 305000000 | USD | 20260212 | Open filing evidence |
| 2025-06-30 – 2025-09-28 | 73000000 | USD | 20251031 | Open filing evidence |
| 2024-12-30 – 2025-09-28 | 225000000 | USD | 20251031 | Open filing evidence |
Product · Sequencing
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=ilmn:SequencingMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-03-30 – 2026-06-28 | 900000000 | USD | 20260731 | Open filing evidence |
| 2025-12-29 – 2026-06-28 | 1743000000 | USD | 20260731 | Open filing evidence |
| 2025-12-29 – 2026-03-29 | 844000000 | USD | 20260504 | Open filing evidence |
| 2024-12-30 – 2025-12-28 | 3404000000 | USD | 20260212 | Open filing evidence |
| 2025-06-30 – 2025-09-28 | 854000000 | USD | 20251031 | Open filing evidence |
| 2024-12-30 – 2025-09-28 | 2494000000 | USD | 20251031 | Open filing evidence |
Service · Microarray
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=ilmn:MicroarrayMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-03-30 – 2026-06-28 | 23000000 | USD | 20260731 | Open filing evidence |
| 2025-12-29 – 2026-06-28 | 46000000 | USD | 20260731 | Open filing evidence |
| 2025-12-29 – 2026-03-29 | 23000000 | USD | 20260504 | Open filing evidence |
| 2024-12-30 – 2025-12-28 | 53000000 | USD | 20260212 | Open filing evidence |
| 2025-06-30 – 2025-09-28 | 10000000 | USD | 20251031 | Open filing evidence |
| 2024-12-30 – 2025-09-28 | 40000000 | USD | 20251031 | Open filing evidence |
Service · Sequencing
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=ilmn:SequencingMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-03-30 – 2026-06-28 | 154000000 | USD | 20260731 | Open filing evidence |
| 2025-12-29 – 2026-06-28 | 306000000 | USD | 20260731 | Open filing evidence |
| 2025-12-29 – 2026-03-29 | 151000000 | USD | 20260504 | Open filing evidence |
| 2024-12-30 – 2025-12-28 | 581000000 | USD | 20260212 | Open filing evidence |
| 2024-12-30 – 2025-09-28 | 425000000 | USD | 20251031 | Open filing evidence |
Scenario Adjustment · Sequencing · IEEPA Tariff Refund
Statement Scenario · Statement Business Segments · Gain Contingencies By Nature
Source dimensions
srt:StatementScenarioAxis=us-gaap:ScenarioAdjustmentMember;us-gaap:StatementBusinessSegmentsAxis=ilmn:SequencingMember;us-gaap:GainContingenciesByNatureAxis=ilmn:IEEPATariffRefundMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-29 – 2026-09-27 | -35000000 | USD | 20261030 | Open filing evidence |
| 2025-12-29 – 2026-09-27 | -35000000 | USD | 20261030 | Open filing evidence |
Scenario Adjustment · Sequencing · IEEPA Tariff Refund · Consumables
Statement Scenario · Statement Business Segments · Gain Contingencies By Nature · Product Or Service
Source dimensions
srt:StatementScenarioAxis=us-gaap:ScenarioAdjustmentMember;us-gaap:StatementBusinessSegmentsAxis=ilmn:SequencingMember;us-gaap:GainContingenciesByNatureAxis=ilmn:IEEPATariffRefundMember;srt:ProductOrServiceAxis=ilmn:ConsumablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-29 – 2026-09-27 | -28000000 | USD | 20261030 | Open filing evidence |
| 2025-12-29 – 2026-09-27 | -28000000 | USD | 20261030 | Open filing evidence |
Scenario Adjustment · Sequencing · IEEPA Tariff Refund · Instruments
Statement Scenario · Statement Business Segments · Gain Contingencies By Nature · Product Or Service
Source dimensions
srt:StatementScenarioAxis=us-gaap:ScenarioAdjustmentMember;us-gaap:StatementBusinessSegmentsAxis=ilmn:SequencingMember;us-gaap:GainContingenciesByNatureAxis=ilmn:IEEPATariffRefundMember;srt:ProductOrServiceAxis=ilmn:InstrumentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-29 – 2026-09-27 | -4000000 | USD | 20261030 | Open filing evidence |
| 2025-12-29 – 2026-09-27 | -4000000 | USD | 20261030 | Open filing evidence |
Core Illumina · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ilmn:CoreIlluminaMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-29 – 2026-09-27 | 1129000000 | USD | 20261030 | Open filing evidence |
| 2025-12-29 – 2026-09-27 | 3380000000 | USD | 20261030 | Open filing evidence |
Microarray
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ilmn:MicroarrayMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-29 – 2026-09-27 | 108000000 | USD | 20261030 | Open filing evidence |
| 2025-12-29 – 2026-09-27 | 309000000 | USD | 20261030 | Open filing evidence |
| 2026-03-30 – 2026-06-28 | 105000000 | USD | 20260731 | Open filing evidence |
| 2025-12-29 – 2026-06-28 | 202000000 | USD | 20260731 | Open filing evidence |
| 2025-12-29 – 2026-03-29 | 96000000 | USD | 20260504 | Open filing evidence |
| 2024-12-30 – 2025-12-28 | 358000000 | USD | 20260212 | Open filing evidence |
Microarray · Consumables
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ilmn:MicroarrayMember;srt:ProductOrServiceAxis=ilmn:ConsumablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-29 – 2026-09-27 | 77000000 | USD | 20261030 | Open filing evidence |
| 2025-12-29 – 2026-09-27 | 225000000 | USD | 20261030 | Open filing evidence |
Microarray · Instruments
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ilmn:MicroarrayMember;srt:ProductOrServiceAxis=ilmn:InstrumentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-29 – 2026-09-27 | 3000000 | USD | 20261030 | Open filing evidence |
| 2025-12-29 – 2026-09-27 | 10000000 | USD | 20261030 | Open filing evidence |
Microarray · Product
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ilmn:MicroarrayMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-29 – 2026-09-27 | 80000000 | USD | 20261030 | Open filing evidence |
| 2025-12-29 – 2026-09-27 | 235000000 | USD | 20261030 | Open filing evidence |
Microarray · Service
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ilmn:MicroarrayMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-29 – 2026-09-27 | 28000000 | USD | 20261030 | Open filing evidence |
| 2025-12-29 – 2026-09-27 | 74000000 | USD | 20261030 | Open filing evidence |
Sequencing
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ilmn:SequencingMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-29 – 2026-09-27 | 1021000000 | USD | 20261030 | Open filing evidence |
| 2025-12-29 – 2026-09-27 | 3071000000 | USD | 20261030 | Open filing evidence |
| 2026-03-30 – 2026-06-28 | 1054000000 | USD | 20260731 | Open filing evidence |
| 2025-12-29 – 2026-06-28 | 2049000000 | USD | 20260731 | Open filing evidence |
| 2025-12-29 – 2026-03-29 | 995000000 | USD | 20260504 | Open filing evidence |
| 2024-12-30 – 2025-12-28 | 3985000000 | USD | 20260212 | Open filing evidence |
Sequencing · Consumables
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ilmn:SequencingMember;srt:ProductOrServiceAxis=ilmn:ConsumablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-29 – 2026-09-27 | 764000000 | USD | 20261030 | Open filing evidence |
| 2025-12-29 – 2026-09-27 | 2265000000 | USD | 20261030 | Open filing evidence |
Sequencing · Instruments
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ilmn:SequencingMember;srt:ProductOrServiceAxis=ilmn:InstrumentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-29 – 2026-09-27 | 102000000 | USD | 20261030 | Open filing evidence |
| 2025-12-29 – 2026-09-27 | 345000000 | USD | 20261030 | Open filing evidence |
Sequencing · Product
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ilmn:SequencingMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-29 – 2026-09-27 | 866000000 | USD | 20261030 | Open filing evidence |
| 2025-12-29 – 2026-09-27 | 2610000000 | USD | 20261030 | Open filing evidence |
Sequencing · Service
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ilmn:SequencingMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-29 – 2026-09-27 | 155000000 | USD | 20261030 | Open filing evidence |
| 2025-12-29 – 2026-09-27 | 461000000 | USD | 20261030 | Open filing evidence |